MRL VENTURES FUND
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.
MRL VENTURES FUND
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Status:
Active
Total Funding:
16 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Nginx Amazon DMARC Amazon SSL Amazon CloudFront AWS Global Accelerator ATT DNS
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
aMoon Fund
aMoon is a leading healthtech & life sciences venture capital firm.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Levianix LLC
Levianix, an alternative asset management fund, serves as a private-sector bailout of the mental and behavioral healthcare industry.
MaRS Discovery District
MaRS is a non-profit organization that partners with entrepreneurs, researchers, business and government.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
MorganFranklin Consulting
MorganFranklin is a strategy and execution-focused business consulting firm and professional advisor.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Photys Therapeutics | MRL Ventures Fund investment in Series A - Photys Therapeutics | 75 M USD |
| 2022-08-25 | Aktis Oncology | MRL Ventures Fund investment in Series A - Aktis Oncology | 84 M USD |
| 2022-03-23 | LifeMine Therapeutics | MRL Ventures Fund investment in Series C - LifeMine Therapeutics | 175 M USD |
| 2022-02-22 | Eyebiotech | MRL Ventures Fund investment in Series A - Eyebiotech | 65 M USD |
| 2022-01-06 | AmbAgon Therapeutics | MRL Ventures Fund investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-10-26 | Mozart Therapeutics | MRL Ventures Fund investment in Series A - Mozart Therapeutics | 55 M USD |
| 2021-07-15 | PAQ Therapeutics | MRL Ventures Fund investment in Series A - PAQ Therapeutics | 30 M USD |
| 2021-05-10 | Therini Bio | MRL Ventures Fund investment in Seed Round - Therini Bio | 17 M USD |
| 2021-03-31 | Entrada Therapeutics | MRL Ventures Fund investment in Series B - Entrada Therapeutics | 116 M USD |
| 2021-03-01 | Carisma Therapeutics | MRL Ventures Fund investment in Series B - Carisma Therapeutics | 12 M USD |